Etude des mécanismes cellulaires et moléculaires de l'inhibition de l'érythropoïèse par la cytokine pro-inflammatoire Tumor necrosis factor (TNF)-alpha

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Unknown venue

• Publication date

  2011-11-14

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Erythropoietin, erythropoiesis and beyond.

  2011cited by this paper
• Tumor necrosis factor α-mediated inhibition of erythropoiesis involves GATA-1/GATA-2 balance impairment and PU.1 over-expression.

  2011cited by this paper
• Erythropoietin Requires Endothelial Nitric Oxide Synthase to Counteract TNF-&agr;-Induced Microcirculatory Dysfunction in Murine Striated Muscle

  2011cited by this paper
• Acute erythropoietin cardioprotection is mediated by endothelial response

  2011cited by this paper
• Oxygen-regulated expression of the erythropoietin gene in the human renal cell line REPC.

  2011cited by this paper
• Effects of recombinant human erythropoietin in normal humans

  2011cited by this paper
• A Large Gene Network in Immature Erythroid Cells Is Controlled by the Myeloid and B Cell Transcriptional Regulator PU.1

  2011cited by this paper
• Erythropoietin protects the developing retina in an ovine model of endotoxin-induced retinal injury.

  2011cited by this paper
• Erythropoietin Protects Pancreatic β-cell Line NIT-1 Cells Against Cytokine-Induced Apoptosis via Phosphatidylinositol 3-Kinase/Akt Signaling

  2011cited by this paper
• Non-erythropoietic erythropoietin derivatives protect from light-induced and genetic photoreceptor degeneration

  2011cited by this paper
• The PI3K/Akt/mTOR pathway mediates retinal progenitor cell survival under hypoxic and superoxide stress.

  2011cited by this paper
• Erythropoietin (EPO) affords more potent cardioprotection by activation of distinct signaling to mitochondrial kinases compared with carbamylated EPO

  2011cited by this paper
• A novel specific application of pyruvate protects the mouse retina against white light damage: differential stabilization of HIF-1α and HIF-2α.

  2011cited by this paper
• Effect of erythropoietin on the proliferation and apoptosis of neonatal porcine islet cells.

  2010cited by this paper
• Chronic IFN-γ production in mice induces anemia by reducing erythrocyte life span and inhibiting erythropoiesis through an IRF-1/PU.1 axis.

  2010cited by this paper
• A peptide-based erythropoietin-receptor agonist for pure red-cell aplasia.

  2010cited by this paper
• Erythropoietin Improves Histological and Functional Outcomes after Traumatic Brain Injury in Mice in the Absence of the Neural Erythropoietin Receptor

  2010cited by this paper
• Pro-Inflammatory Cytokine-Mediated Anemia: Regarding Molecular Mechanisms of Erythropoiesis

  2010cited by this paper
• Erythropoietin for infants with hypoxic–ischemic encephalopathy

  2010cited by this paper
• Hepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemia.

  2010cited by this paper
• [Erythropoietin and neuroprotection].

  2010cited by this paper
• Erythropoietin protects against diabetes through direct effects on pancreatic β cells

  2010cited by this paper
• Hypoxia inducible factor 1 (HIF-1) and cardioprotection

  2010cited by this paper
• Cardioprotection by a nonerythropoietic, tissue-protective peptide mimicking the 3D structure of erythropoietin

  2010cited by this paper
• Sonic hedgehog is a critical mediator of erythropoietin-induced cardiac protection in mice.

  2010cited by this paper
• Prolyl hydroxylase domain-containing protein inhibitors as stabilizers of hypoxia-inducible factor: small molecule-based therapeutics for anemia

  2010cited by this paper
• Non-erythropoietic tissue-protective peptides derived from erythropoietin: WO2009094172

  2010cited by this paper
• Down-regulation of GATA1 uncouples STAT5-induced erythroid differentiation from stem/progenitor cell proliferation.

  2010cited by this paper
• Histone deacetylase inhibition modulates cell fate decisions during myeloid differentiation

  2010cited by this paper
• Molecular and Therapeutic Potential and Toxicity of Valproic Acid

  2010cited by this paper
• Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling

  2010cited by this paper
• Enhanced Oligodendrogenesis and Recovery of Neurological Function by Erythropoietin After Neonatal Hypoxic/Ischemic Brain Injury

  2010cited by this paper
• Benefits and harms of erythropoiesis-stimulating agents for anemia related to cancer: a meta-analysis

  2009cited by this paper
• Isoform-specific histone deacetylase inhibitors: the next step?

  2009cited by this paper
• Linking anemia to inflammation and cancer: the crucial role of TNFalpha.

  2009influential reference
• c-Myc-mediated control of cell fate in megakaryocyte-erythrocyte progenitors.

  2009cited by this paper
• Apollo: a community resource for genome annotation editing

  2009cited by this paper
• Hematide™ for the treatment of chronic kidney disease-related anemia

  2009cited by this paper
• Carbamylated darbepoetin derivative prevents endothelial progenitor cell damage with no effect on angiogenesis.

  2009cited by this paper
• The inhibitory effect of the proinflammatory cytokine TNFalpha on erythroid differentiation involves erythroid transcription factor modulation.

  2009influential reference
• Erythropoietin attenuates white matter damage, proinflammatory cytokine and chemokine induction in developing rat brain after intra‐uterine infection

  2009cited by this paper
• GATA-2 Reinforces Megakaryocyte Development in the Absence of GATA-1

  2009cited by this paper
• Myocardial reperfusion injury management: erythropoietin compared with postconditioning.

  2009cited by this paper
• Polycythemia vera erythroid precursors exhibit increased proliferation and apoptosis resistance associated with abnormal RAS and PI3K pathway activation.

  2009cited by this paper
• Molecular basis of cardioprotection by erythropoietin.

  2009cited by this paper
• Erythropoietin: a possible cytoprotective cytokine in acute necrotizing pancreatitis.

  2009cited by this paper
• Examining the involvement of erythropoiesis-stimulating agents in tumor proliferation (erythropoietin receptors, receptor binding, signal transduction), angiogenesis, and venous thromboembolic events.

  2009cited by this paper
• FOXO Transcription Factors Enforce Cell Cycle Checkpoints and Promote Survival of Hematopoietic Cells after DNA Damage

  2009cited by this paper
• Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials.

  2009cited by this paper
• Erythropoietin Protects against Doxorubicin-Induced Cardiomyopathy via a Phosphatidylinositol 3-Kinase-Dependent Pathway

  2008cited by this paper
• Carbamylated Erythropoietin Improves Angiogenesis and Protects the Kidneys from Ischemia-Reperfusion Injury

  2008cited by this paper
• Nonerythropoietic derivative of erythropoietin protects against tubulointerstitial injury in a unilateral ureteral obstruction model.

  2008cited by this paper
• Developments in the therapeutic use of erythropoiesis stimulating agents

  2008cited by this paper
• Paracrine effects of hypoxic fibroblast-derived factors on the MPT-ROS threshold and viability of adult rat cardiac myocytes.

  2008cited by this paper
• Cancer-related inflammation

  2008cited by this paper
• Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update.

  2008cited by this paper
• Maximal STAT5-Induced Proliferation and Self-Renewal at Intermediate STAT5 Activity Levels

  2008cited by this paper
• Erythropoietin enhancement of rat pancreatic tumor cell proliferation requires the activation of ERK and JNK signals.

  2008cited by this paper
• Radicicol‐mediated inhibition of Bcr‐Ab1 in K562 cells induced p38‐MAPK dependent erythroid differentiation and PU.1 down‐regulation

  2008cited by this paper
• Role of p38 in regulation of hematopoiesis: effect of p38 inhibition on cytokine production and transcription factor activity in human bone marrow stromal cells.

  2008cited by this paper
• High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO)

  2008cited by this paper
• Neurite outgrowth on cultured spiral ganglion neurons induced by erythropoietin.

  2008cited by this paper
• C/EBP alpha:AP-1 leucine zipper heterodimers bind novel DNA elements, activate the PU.1 promoter and direct monocyte lineage commitment more potently than C/EBP alpha homodimers or AP-1.

  2008cited by this paper
• Risks of Venous Thromboembolism and Mortality Associated With Erythropoiesis-Stimulating Agents for the Treatment of Cancer-Associated Anemia.

  2008cited by this paper
• Hypoxic preconditioning protects rat hearts against ischaemia–reperfusion injury: role of erythropoietin on progenitor cell mobilization

  2008cited by this paper
• Tumor necrosis factor alpha inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation.

  2008influential reference
• Hematopoiesis: an evolving paradigm for stem cell biology.

  2008cited by this paper
• Valproic Acid Sensitizes Chronic Lymphocytic Leukemia Cells to Apoptosis and Restores the Balance Between Pro- and Antiapoptotic Proteins

  2008cited by this paper
• The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages.

  2008cited by this paper
• Expression of Erythropoietin and Its Receptor in the Human Retina

  2008cited by this paper
• Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin

  2008cited by this paper
• Erythropoietin receptors on tumor cells: what do they mean?

  2008cited by this paper
• TNF receptor I sensitizes neurons to erythropoietin- and VEGF-mediated neuroprotection after ischemic and excitotoxic injury

  2008cited by this paper
• Expression of EPO receptor in pancreatic cells and its effect on cell apoptosis

  2008cited by this paper
• Essential role for Stat5 in the neurotrophic but not in the neuroprotective effect of erythropoietin

  2008cited by this paper
• Erythropoietin in Cancer: Presumption of Innocence?

  2007cited by this paper
• Auditory processing and learning/memory following erythropoietin administration in neonatally hypoxic-ischemic injured rats.

  2007cited by this paper
• Use of gene-manipulated mice in the study of erythropoietin gene expression.

  2007cited by this paper
• Downregulation of c-Myc is critical for valproic acid-induced growth arrest and myeloid differentiation of acute myeloid leukemia.

  2007cited by this paper
• Role of hypoxia-inducible factor-2alpha in endothelial development and hematopoiesis.

  2007cited by this paper
• Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1

  2007cited by this paper
• Transcriptional control of granulocyte and monocyte development

  2007cited by this paper
• Darbepoetin alfa once every 2 weeks for treatment of anemia in dialysis patients: a combined analysis of eight multicenter trials.

  2007cited by this paper
• Erythropoietin (EPO): EPO-receptor signaling improves early endochondral ossification and mechanical strength in fracture healing.

  2007cited by this paper
• Reduction in PU.1 activity results in a block to B-cell development, abnormal myeloid proliferation, and neonatal lethality.

  2007cited by this paper
• Important Role of Erythropoietin Receptor to Promote VEGF Expression and Angiogenesis in Peripheral Ischemia in Mice

  2007cited by this paper
• Erythropoietin Attenuates Lipopolysaccharide-Induced White Matter Injury in the Neonatal Rat Brain

  2007cited by this paper
• Myeloid lineage commitment from the hematopoietic stem cell.

  2007cited by this paper
• Cytokine receptors and hematopoietic differentiation

  2007cited by this paper
• Altered macrophage differentiation and immune dysfunction in tumor development.

  2007cited by this paper
• Reduced Functional Deficits, Neuroinflammation, and Secondary Tissue Damage after Treatment of Stroke by Nonerythropoietic Erythropoietin Derivatives

  2007cited by this paper
• Acetylation and MAPK phosphorylation cooperate to regulate the degradation of active GATA-1.

  2007cited by this paper
• Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia.

  2007cited by this paper
• Control of erythropoietin gene expression and its use in medicine.

  2007cited by this paper
• Erythropoietin Promotes Neuronal Replacement Through Revascularization and Neurogenesis After Neonatal Hypoxia/Ischemia in Rats

  2007cited by this paper
• Erythroid and megakaryocytic transformation

  2007cited by this paper
• A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells.

  2007cited by this paper
• Human recombinant erythropoietin protects the striated muscle microcirculation of the dorsal skinfold from postischemic injury in mice.

  2007cited by this paper
• Erythropoietin promotes survival of retinal ganglion cells in DBA/2J glaucoma mice.

  2007cited by this paper
• Dynamic regulation of Gata factor levels is more important than their identity.

  2007influential reference

• No citing papers are available for this paper.